Inhibitors Against Iron-Overload Diseases

  • Author: Ruben Ragg
  • Published Date: 03 June 2016
  • Source / Publisher: Chemistry – A European Journal/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
thumbnail image: Inhibitors Against Iron-Overload Diseases

Related Societies

Serine proteases are ubiquitous peptidases in which serine acts as nucleophile for a peptide bond cleavage in the enzyme's active site. The human type II transmembrane serine protease matripase-2 plays a key role in iron homeostasis, i.e, regulating iron levels. Inhibition of matripase-2 is therefore considered an attractive target for the treatment of iron-overload diseases. However, small molecule inhibitors of matripase-2 are rare.


Michael Gütschow, University of Bonn, Germany, and colleagues synthesized nine different dipeptidomimetic inactivators of matripase-2. The compounds contain one phosphonate warhead (pictured blue) and two benzguanidine moieties (pictured red), which act as arginine mimetics. These groups provide affinity for matriptase-2.


Five of the compounds were identified as irreversible inhibitors of matripase-2. R-configured epimers at the phosphonate carbon atom were significantly more potent than the corresponding S-epimers. Consequently, one of the synthesized R-epimers is the most potent irreversible inhibitor of matriptase-2 known so far. The addition of coumarin as a fluorescent label into the same phosphono bisbenzguanidine inhibitor generated the first activity-based fluorescent probe for matripase-2.


The synthesized compounds might serve as a suitable starting point for the further development of irreversible matriptase-2 inactivators and as valuable tools for future investigations of the key role of matriptase-2 in iron homeostasis.


 

Article Views: 3154

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission and consult our permission guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH